These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 10779416)
1. Role of SUMO-1-modified PML in nuclear body formation. Zhong S; Müller S; Ronchetti S; Freemont PS; Dejean A; Pandolfi PP Blood; 2000 May; 95(9):2748-52. PubMed ID: 10779416 [TBL] [Abstract][Full Text] [Related]
2. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. Zhong S; Salomoni P; Ronchetti S; Guo A; Ruggero D; Pandolfi PP J Exp Med; 2000 Feb; 191(4):631-40. PubMed ID: 10684855 [TBL] [Abstract][Full Text] [Related]
3. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. Ishov AM; Sotnikov AG; Negorev D; Vladimirova OV; Neff N; Kamitani T; Yeh ET; Strauss JF; Maul GG J Cell Biol; 1999 Oct; 147(2):221-34. PubMed ID: 10525530 [TBL] [Abstract][Full Text] [Related]
4. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Chelbi-Alix MK; de Thé H Oncogene; 1999 Jan; 18(4):935-41. PubMed ID: 10023669 [TBL] [Abstract][Full Text] [Related]
5. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Lehembre F; Müller S; Pandolfi PP; Dejean A Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500 [TBL] [Abstract][Full Text] [Related]
6. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. Sternsdorf T; Jensen K; Will H J Cell Biol; 1997 Dec; 139(7):1621-34. PubMed ID: 9412458 [TBL] [Abstract][Full Text] [Related]
7. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies. Engelhardt OG; Ullrich E; Kochs G; Haller O Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541 [TBL] [Abstract][Full Text] [Related]
8. A role for PML and the nuclear body in genomic stability. Zhong S; Hu P; Ye TZ; Stan R; Ellis NA; Pandolfi PP Oncogene; 1999 Dec; 18(56):7941-7. PubMed ID: 10637504 [TBL] [Abstract][Full Text] [Related]
9. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266 [TBL] [Abstract][Full Text] [Related]
10. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. Lallemand-Breitenbach V; Zhu J; Puvion F; Koken M; Honoré N; Doubeikovsky A; Duprez E; Pandolfi PP; Puvion E; Freemont P; de Thé H J Exp Med; 2001 Jun; 193(12):1361-71. PubMed ID: 11413191 [TBL] [Abstract][Full Text] [Related]
11. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386 [TBL] [Abstract][Full Text] [Related]
12. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. Müller S; Dejean A J Virol; 1999 Jun; 73(6):5137-43. PubMed ID: 10233977 [TBL] [Abstract][Full Text] [Related]
13. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. Müller S; Matunis MJ; Dejean A EMBO J; 1998 Jan; 17(1):61-70. PubMed ID: 9427741 [TBL] [Abstract][Full Text] [Related]
14. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. Duprez E; Saurin AJ; Desterro JM; Lallemand-Breitenbach V; Howe K; Boddy MN; Solomon E; de Thé H; Hay RT; Freemont PS J Cell Sci; 1999 Feb; 112 ( Pt 3)():381-93. PubMed ID: 9885291 [TBL] [Abstract][Full Text] [Related]
15. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. Engelhardt OG; Boutell C; Orr A; Ullrich E; Haller O; Everett RD Exp Cell Res; 2003 Feb; 283(1):36-50. PubMed ID: 12565818 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10. Bell P; Brazas R; Ganem D; Maul GG J Virol; 2000 Jun; 74(11):5329-36. PubMed ID: 10799610 [TBL] [Abstract][Full Text] [Related]
17. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53. Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925 [TBL] [Abstract][Full Text] [Related]
18. Death-domain associated protein-6 (DAXX) mediated apoptosis in hantavirus infection is counter-balanced by activation of interferon-stimulated nuclear transcription factors. Khaiboullina SF; Morzunov SP; Boichuk SV; Palotás A; St Jeor S; Lombardi VC; Rizvanov AA Virology; 2013 Sep; 443(2):338-48. PubMed ID: 23830076 [TBL] [Abstract][Full Text] [Related]
20. Regulation of p53 activity in nuclear bodies by a specific PML isoform. Fogal V; Gostissa M; Sandy P; Zacchi P; Sternsdorf T; Jensen K; Pandolfi PP; Will H; Schneider C; Del Sal G EMBO J; 2000 Nov; 19(22):6185-95. PubMed ID: 11080164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]